VITA 34 partners with CompuGROUP to inform doctors on umbilical cord blood

(PresseBox) ( Leipzig, )
VITA 34 International AG (ISIN DE000A0BL849), the parent company of the largest private umbilical cord blood bank in the Germanspeaking countries VITA 34, has entered a sales cooperation with the CompuGROUP Holding AG. In the course of this partnership, comprehensive information on the storage of umbilical cord blood will be communicated by means of the medical information systems offered by CompuGROUP, one of the leading eHealth enterprises in Europe. VITA 34 aims at increasing the quality and intensity of the medical advice as to the storage of umbilical cord blood significantly and thus remedying the lack of information of many parentstobe.

Dr. med. Eberhard Lampeter, VITA 34 CEO, says: 'The offered information forms should be an efficient possibility for gynecologists particularly to inform their patients.'

Uwe Eibich, Executive Vice President Central Europe of the CompuGROUP, adds: 'The innovative products of VITA 34 and CompuGROUP stand for best health care and highest quality. We are pleased that we can provide this wide range of information related to umbilical cord blood together with VITA 34.'

The VITA 34 management board is going to hold a telephone conference for investors, analysts, and media representatives today, March 8, 2010, at 11:30 a.m., during which the partnership will be explained in detail and the company's prospect for the coming quarters described. For all the necessary dialin data to access the conference call, contact Rainer Brändle, edicto GmbH, at +49 69 905505-50 or by email to
The publisher indicated in each case is solely responsible for the press releases above, the event or job offer displayed, and the image and sound material used (see company info when clicking on image/message title or company info right column). As a rule, the publisher is also the author of the press releases and the attached image, sound and information material.
The use of information published here for personal information and editorial processing is generally free of charge. Please clarify any copyright issues with the stated publisher before further use. In the event of publication, please send a specimen copy to